Story perspectives

Takeda CEO Christophe Weber to Retire; Julie Kim Named Successor

1/31/2025

32 7

Summary

Story summary

Takeda CEO Christophe Weber will retire in June 2026 after 12 years, with Julie Kim as his successor.
Kim's appointment follows a thorough succession planning process and unanimous board approval.
Under Weber's leadership, Takeda's revenue nearly doubled, including a major acquisition of Shire for $62 billion.
Kim brings over 30 years of healthcare experience and will be nominated for board membership in 2026.
Takeda, based in Japan, specializes in global biopharmaceutical innovations.

1 of 1

Story summary

Takeda CEO Christophe Weber will retire in June 2026 after 12 years, with Julie Kim as his successor.
Kim's appointment follows a thorough succession planning process and unanimous board approval.
Under Weber's leadership, Takeda's revenue nearly doubled, including a major acquisition of Shire for $62 billion.
Kim brings over 30 years of healthcare experience and will be nominated for board membership in 2026.
Takeda, based in Japan, specializes in global biopharmaceutical innovations.